Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma 7Leukemia, Lymphocytic, Chronic, B-Cell 7Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Burkitt Lymphoma 5Lymphoma, Mantle-Cell 4Leukemia, Myeloid, Acute 4Waldenstrom Macroglobulinemia 3Hematologic Neoplasms 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neutropenia 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Prolymphocytic 2Neoplasms 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myeloid 1Bronchiolitis Obliterans Syndrome 1Blast Crisis 1

Interventions

Cytarabine 14fludarabine 13venetoclax 11Imatinib Mesylate 9Cyclophosphamide 8Azacitidine 8fludarabine phosphate 7Busulfan 7Whole-Body Irradiation 6Tacrolimus 6Mycophenolic Acid 6thymoglobulin 4ponatinib 4nilotinib 4Sirolimus 4Peripheral Blood Stem Cell Transplantation 4Methotrexate 4asciminib 3aldesleukin 3Melphalan 3Interleukin-2 3Idarubicin 3Granulocyte Colony-Stimulating Factor 3Filgrastim 3Decitabine 3Bone Marrow Transplantation 3Antilymphocyte Serum 3zosuquidar trihydrochloride 2gilteritinib 2enasidenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Myeloid × pegfilgrastim × Other hematologic neoplasm × Clear all
NCT00114764 2008-10-31

Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)

Amgen

Phase 2 Completed
84 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Neutropenia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡